| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ideaya Biosciences, Inc. (IDYA) has 6 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. IDYA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 20.0K | $564.4K | - | |
| ? | 20.0K | $564.4K | - | |
| ? | 20.0K | $564.4K | - | |
| ? | 20.0K | $564.4K | - | |
| ? | 20.0K | $564.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 28, 2019 | Stone Paul A. | SVP, General Counsel | Buy | 250,000 | $10.00 | $2,500,000.00 | +9.2% | |
| May 28, 2019 | 5am Ventures Iv, L.P. | 10% Owner | Buy | 750,000 | $10.00 | $7,500,000.00 | +27.6% | |
| May 28, 2019 | Diekman John D77 | Director | Buy | 250,000 | $10.00 | $2,500,000.00 | +9.2% |